Modified peptide of human acidic fibroblast growth factor

Details Modified peptide of human acidic fibroblast growth factor Modified peptide of human acidic fibroblast growth factor

2011-06-07

2011-06-07

Allen, Marianne P (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000, C530S399000

Reexamination Certificate

active

07956033

ABSTRACT:
An modified peptide of human acidic fibroblast growth factor (aFGF), comprising a native human aFGF shortened by a deletion of a deletion of 20 amino acids from N-terminal of the native human aFGF, and an addition of Alanine (Ala) before the shortened native aFGF is provided.

REFERENCES:
patent: 7282481 (2007-10-01), Imamura et al.
patent: 7741078 (2010-06-01), Imamura et al.
patent: 2009/0305988 (2009-12-01), Cheng et al.
patent: 11 2005 000 737 (2007-04-01), None
patent: 2000236880 (2000-09-01), None
patent: 02/14471 (2002-02-01), None
patent: WO 2005/095600 (2005-10-01), None

Affiliated with

Also associated with

Rating

Modified peptide of human acidic fibroblast growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified peptide of human acidic fibroblast growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified peptide of human acidic fibroblast growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2726908